Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS) (MITOTARGET)

This study has been completed.
Sponsor:
Collaborator:
European Commission
Information provided by (Responsible Party):
Trophos
ClinicalTrials.gov Identifier:
NCT00868166
First received: March 23, 2009
Last updated: March 27, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)